ArticleOncotarget2017

The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance.

Christopher D Suarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.